Scarica l'app Stockscreener
0.2272
4.82%
-0.0115
Pre-mercato:
.23
0.0028
+1.23%
Precedente Chiudi:
$0.2387
Aprire:
$0.245
Volume 24 ore:
196.46K
Relative Volume:
0.03
Capitalizzazione di mercato:
$10.21M
Reddito:
$3.50M
Utile/perdita netta:
$-37.33M
Rapporto P/E:
-0.2272
EPS:
-1
Flusso di cassa netto:
$-19.15M
1 W Prestazione:
-24.27%
1M Prestazione:
-36.31%
6M Prestazione:
-49.57%
1 anno Prestazione:
-85.62%
Intervallo 1D:
$0.2178
$0.245
Intervallo di 1 settimana:
$0.2178
$0.296
Portata 52W:
$0.2103
$2.52
Hcw Biologics Inc Stock (HCWB) Company Profile
Nome
Hcw Biologics Inc
Settore
Industria
Telefono
954-842-2024
Indirizzo
2929 N COMMERCE PKWY, MIRAMAR
Confronta HCWB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HCWB
Hcw Biologics Inc
|
0.2272 | 10.21M | 3.50M | -37.33M | -19.15M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Hcw Biologics Inc Borsa (HCWB) Ultime notizie
HCW Biologics Stock Set to Reverse Split on Friday, April 11th (NASDAQ:HCWB) - Defense World
HCW Biologics to Implement 1-for-40 Reverse Stock Split - MarketScreener
HCW Biologics approves reverse stock split to meet Nasdaq rules By Investing.com - Investing.com South Africa
HCW Biologics Announces 1-for-40 Reverse Stock Split - citybiz
HCW Biologics approves reverse stock split - Investing.com India
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
HCW Biologics approves reverse stock split to meet Nasdaq rules - Investing.com
HCW Biologics approves 1-for-40 reverse stock split - TipRanks
HCW Biologics Announces 1-For-40 Reverse Stock Split - MarketScreener
Major Stock Restructuring: HCW Biologics Announces 40:1 Reverse Split for Nasdaq Compliance - Stock Titan
Warner Bros Discovery Stock (NASDAQ:WBD) Slides as Film Boss Replacements Considered - The Globe and Mail
HCW BIOLOGICS Earnings Preview: Recent $HCWB Insider Trading, Hedge Fund Activity, and More - Nasdaq
HCW Biologics Reports Fourth Quarter and Fiscal Year 2024 Business Highlights and Financial Results - GlobeNewswire
HCW Biologics Inc. SEC 10-K Report - TradingView
HCW Biologics Secures FDA Green Light for Alopecia Treatment Despite $30M Annual Loss - Stock Titan
HCW Biologics amends agreement with WY Biotech amid delays - Investing.com
Stocks Attempt to Stabilize as Trump Set to Meet with Top US Executives - The Globe and Mail
HCW Biologics Granted Extension by the Nasdaq Hearings - GlobeNewswire
HCW Biologics Inc. Receives Extension from Nasdaq to Regain Compliance with Listing Rules - Nasdaq
Can HCW Biologics Meet Nasdaq's New June Deadline? Key Details Revealed - StockTitan
HCW Biologics Inc. announced that it expects to receive $20 million in funding -February 19, 2025 - Marketscreener.com
Zeta (ZETA) Q4 Earnings: What To Expect - The Globe and Mail
HCW Biologics Inc (HCWB) is looking forward to a strong quarter - SETE News
HCW Biologics Inc Inc. (HCWB) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle
Navigating the Volatility of HCW Biologics Inc’s (HCWB) Stock - The News Heater
Trading Day Review: HCW Biologics Inc (HCWB) Loses Momentum, Closing at 0.43 - The Dwinnex
The Business Case For Buying HCW Biologics Inc (NASDAQ: HCWB) Stock Now - Stocks Register
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
HCW Biologics: Buy Rating Affirmed Amid IND Clearance and Strategic Advancements - TipRanks
HCW-9302 gains IND clearance for first-in-human study in alopecia areata - BioWorld Online
Why Palantir Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket - Benzinga
HCW Biologics Inc Inc. (HCWB) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle
Penny Stocks To ResearchFebruary 03rd - MarketBeat
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Pharma company granted FDA clearance for alopecia drug study - The Business Journals
Crude Oil Moves Higher; Owens & Minor Shares Plummet - Benzinga
FDA approves HCW Biologics trial for alopecia treatment - MSN
What's Going On With HCW Biologics Stock Monday? - Benzinga
A Potential Breakthrough in the Fight Against Alopecia Areata: What You Need to Know About HCW Biologics Inc. - RagingBull
Stock market news: MDJM surged by 74.54% while Tonix Pharmaceuticals Holding plunged by 49.31% during mid day trading - Business Upturn
Dow Falls 150 Points; ISM Manufacturing PMI Rises In January - Benzinga
S&P 500 Down Over 1%; Tyson Foods Posts Upbeat Results - Benzinga
HCW Biologics Advances with FDA Clearance for Trial - TipRanks
Stock market today: Tonix Pharmaceuticals Holding declined by 49.01% whereas HCW Biologics jumped by 176.78% in early trading - Business Upturn
HCW Biologics Says FDA Approves Trial of HCW9302 to Treat Alopecia Areata; Shares Rise Pre-Bell - Marketscreener.com
HCW Biologics Granted FDA Clearance to Evaluate One of the - GlobeNewswire
HCW Biologics Granted FDA Clearance to Evaluate One of the Company?s Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial - Marketscreener.com
HCWB stock touches 52-week low at $0.25 amid market challenges - Investing.com Australia
HCW Biologics (NASDAQ:HCWB) Shares Down 20% – Here’s Why - Defense World
HCWB stock touches 52-week low at $0.25 amid market challenges By Investing.com - Investing.com South Africa
Hcw Biologics Inc Azioni (HCWB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):